Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium for post-CABG arrhythmias
IRCT2015092224133N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium in Atrial fibrillation (AFib) and Premature ventricular complexes (PVC), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Effect on post-CABG arrhythmias, Atrial fibrillation and 1 more. Started Apr 2014; status: completed.
02
Drugs
magnesium
03
Conditions
Atrial fibrillation (AFib)Premature ventricular complexes (PVC)
Beyond the preview
Go deeper on IRCT2015092224133N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015092224133N1.